• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼吸道合胞病毒:当前基础与临床知识综述

Respiratory syncytial virus: A review of current basic and clinical knowledge.

作者信息

Al-Leimon Obada, Shihadeh Hani, Yousef Ahmad Ayman, Khraim Anas, Siwwad Rizeq

机构信息

School of Medicine, The University of Jordan, Amman, Jordan *Email:

出版信息

Qatar Med J. 2024 Dec 24;2024(4):56. doi: 10.5339/qmj.2024.56. eCollection 2024.

DOI:10.5339/qmj.2024.56
PMID:39931346
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11809256/
Abstract

BACKGROUND

Respiratory syncytial virus (RSV) is a highly contagious pathogen known for causing respiratory tract infections, particularly among pediatric and elderly patients. Its ability to induce outbreaks in both community and hospital settings underscores its substantial health burden. This review aims to provide a comprehensive understanding of RSV, including its biological and clinical aspects.

METHODS

A comprehensive review of the literature was conducted by searching PubMed, Scopus, and Web of Science databases for relevant articles. Key topics included RSV virology, epidemiology, clinical findings, diagnostic methods, management approaches, and preventive strategies.

RESULTS

This review encompasses the taxonomy and structure of RSV, including its genome and proteins. Various strains and their dominance patterns, alongside pathogenesis mechanisms, are explored. Diagnostic techniques such as nucleic acid amplification tests are discussed for their efficacy and accessibility. Supportive care remains the primary treatment, with antiviral therapies playing a limited role. Monoclonal antibody immunization and vaccination efforts offer promising avenues for RSV prevention. The impact of the COVID-19 pandemic on RSV epidemiology is also considered, along with the oncolytic potential of RSV in cancer treatment.

CONCLUSION

Advancements in understanding RSV virology, epidemiology, and clinical management have paved the way for improved diagnostic and preventive strategies. However, challenges remain in ensuring widespread access to diagnostics and effective treatments, particularly in resource-limited settings. Continued research and global collaboration are essential for addressing the ongoing impact of RSV and reducing its burden on public health.

摘要

背景

呼吸道合胞病毒(RSV)是一种具有高度传染性的病原体,以引起呼吸道感染而闻名,尤其是在儿科和老年患者中。它在社区和医院环境中引发疫情的能力凸显了其巨大的健康负担。本综述旨在全面了解RSV,包括其生物学和临床方面。

方法

通过检索PubMed、Scopus和Web of Science数据库中的相关文章,对文献进行了全面综述。关键主题包括RSV病毒学、流行病学、临床发现、诊断方法、管理方法和预防策略。

结果

本综述涵盖了RSV的分类学和结构,包括其基因组和蛋白质。探讨了各种毒株及其优势模式,以及发病机制。讨论了核酸扩增试验等诊断技术的有效性和可及性。支持性护理仍然是主要治疗方法,抗病毒疗法的作用有限。单克隆抗体免疫和疫苗接种工作为预防RSV提供了有希望的途径。还考虑了COVID-19大流行对RSV流行病学的影响,以及RSV在癌症治疗中的溶瘤潜力。

结论

在理解RSV病毒学、流行病学和临床管理方面的进展为改进诊断和预防策略铺平了道路。然而,在确保广泛获得诊断和有效治疗方面仍存在挑战,特别是在资源有限的环境中。持续的研究和全球合作对于应对RSV的持续影响和减轻其对公共卫生的负担至关重要。

相似文献

1
Respiratory syncytial virus: A review of current basic and clinical knowledge.呼吸道合胞病毒:当前基础与临床知识综述
Qatar Med J. 2024 Dec 24;2024(4):56. doi: 10.5339/qmj.2024.56. eCollection 2024.
2
An Overview on Disease Burden and Management of Respiratory Syncytial Virus Infections in Older Adults in the Asia-Pacific Region.亚太地区老年人呼吸道合胞病毒感染的疾病负担和管理概述。
Rev Med Virol. 2024 Nov;34(6):e70003. doi: 10.1002/rmv.70003.
3
Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options.呼吸道合胞病毒:关于新预防方案的瓦迪德共识文件
Vaccines (Basel). 2024 Nov 25;12(12):1317. doi: 10.3390/vaccines12121317.
4
Respiratory syncytial virus vaccination: likely and less likely outcomes.呼吸道合胞病毒疫苗接种:可能出现的和不太可能出现的结果。
Curr Opin Pediatr. 2025 Jun 1;37(3):259-265. doi: 10.1097/MOP.0000000000001455. Epub 2025 Mar 19.
5
Nirsevimab: Alleviating the burden of RSV morbidity in young children.尼氏单抗:减轻婴幼儿 RSV 发病负担。
J Paediatr Child Health. 2024 Oct;60(10):489-498. doi: 10.1111/jpc.16643. Epub 2024 Aug 16.
6
Effectiveness of nirsevimab immunization against RSV infection in preterm infants: a systematic review and meta-analysis.尼塞韦单抗免疫接种对早产儿呼吸道合胞病毒感染的有效性:一项系统评价和荟萃分析
Front Immunol. 2025 Apr 17;16:1581970. doi: 10.3389/fimmu.2025.1581970. eCollection 2025.
7
The recent landscape of RSV vaccine research.呼吸道合胞病毒疫苗研究的最新概况。
Ther Adv Vaccines Immunother. 2025 Jan 10;13:25151355241310601. doi: 10.1177/25151355241310601. eCollection 2025.
8
The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis.呼吸道合胞病毒预融合 F 蛋白疫苗对日本≥60 岁人群的潜在公共卫生影响:一项马尔可夫模型分析的结果。
Expert Rev Vaccines. 2024 Jan-Dec;23(1):303-311. doi: 10.1080/14760584.2024.2323128. Epub 2024 Mar 1.
9
Evaluation of antibody-based preventive alternatives for respiratory syncytial virus: a novel multi-criteria decision analysis framework and assessment of nirsevimab in Spain.基于抗体的预防呼吸道合胞病毒替代方案的评估:一种新的多标准决策分析框架和尼司特单抗在西班牙的评估。
BMC Infect Dis. 2024 Jan 18;24(1):99. doi: 10.1186/s12879-024-08988-9.
10
Postpandemic fluctuations of regional respiratory syncytial virus hospitalization epidemiology: potential impact on an immunization program in Switzerland.大流行后区域呼吸道合胞病毒住院流行病学波动:对瑞士免疫计划的潜在影响。
Eur J Pediatr. 2024 Dec;183(12):5149-5161. doi: 10.1007/s00431-024-05785-z. Epub 2024 Sep 27.

本文引用的文献

1
Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.2019 年导致早产儿和幼儿急性下呼吸道感染的呼吸道合胞病毒的全球疾病负担及危险因素:汇总和个体参与者数据的系统评价和荟萃分析。
Lancet. 2024 Mar 30;403(10433):1241-1253. doi: 10.1016/S0140-6736(24)00138-7. Epub 2024 Feb 14.
2
An Integrated ddPCR Lab-on-a-Disc Device for Rapid Screening of Infectious Diseases.一种用于传染病快速筛查的集成式数字PCR芯片实验室设备。
Biosensors (Basel). 2023 Dec 21;14(1):2. doi: 10.3390/bios14010002.
3
A multiplex recombinase polymerase amplification assay combined with CRISPR/Cas12a for the detection of respiratory syncytial virus and respiratory adenovirus.一种多重重组酶聚合酶扩增检测法与 CRISPR/Cas12a 联合检测呼吸道合胞病毒和呼吸道腺病毒。
J Int Med Res. 2024 Jan;52(1):3000605231223083. doi: 10.1177/03000605231223083.
4
Respiratory syncytial virus: A new era.呼吸道合胞病毒:新纪元。
Rev Esp Quimioter. 2024 Apr;37(2):134-148. doi: 10.37201/req/147.2023. Epub 2024 Jan 11.
5
Detecting Respiratory Viruses Using a Portable NIR Spectrometer-A Preliminary Exploration with a Data Driven Approach.使用便携式近红外光谱仪检测呼吸道病毒 - 一种基于数据驱动方法的初步探索。
Sensors (Basel). 2024 Jan 4;24(1):308. doi: 10.3390/s24010308.
6
Daily intranasal palivizumab to prevent respiratory syncytial virus infection in healthy preterm infants: a phase 1/2b randomized placebo-controlled trial.每日鼻内注射帕利珠单抗预防健康早产儿呼吸道合胞病毒感染:一项1/2b期随机安慰剂对照试验。
EClinicalMedicine. 2023 Nov 25;66:102324. doi: 10.1016/j.eclinm.2023.102324. eCollection 2023 Dec.
7
Vaccination for Respiratory Syncytial Virus: A Narrative Review and Primer for Clinicians.呼吸道合胞病毒疫苗接种:叙述性综述及临床医生入门指南
Vaccines (Basel). 2023 Dec 2;11(12):1809. doi: 10.3390/vaccines11121809.
8
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults.基于 mRNA 的 RSV 前体疫苗在老年人中的疗效和安全性。
N Engl J Med. 2023 Dec 14;389(24):2233-2244. doi: 10.1056/NEJMoa2307079.
9
Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children: Rationale and Progress to Date.儿童呼吸道合胞病毒感染的预防和治疗方法:原理和迄今为止的进展。
Paediatr Drugs. 2024 Mar;26(2):101-112. doi: 10.1007/s40272-023-00606-6. Epub 2023 Nov 30.
10
Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines.呼吸道合胞病毒疫苗:候选疫苗及获批疫苗综述
Pathogens. 2023 Oct 19;12(10):1259. doi: 10.3390/pathogens12101259.